Analyst Richard Close from Canaccord Genuity maintained a Buy rating on Clover Health Investments (CLOV – Research Report) and keeping ...

A research team has identified a wealth of bioactive compounds in red clover (Trifolium pratense) seeds and their oil, ...

On Friday, Clover Health Investments Corp (CLOV) stock saw a modest uptick, ending the day at $4.07 which represents a slight increase of $0.12 or 3.04% from the prior close of $3.95. The stock opened ...

Overall Star rating performance increase was driven by exceptional performance on healthcare quality measures, Medication Adherence and Member ExperienceFRANKLIN, Tenn., Oct. 10, 2024 (GLOBE NEWSWIRE) ...

A research team has identified a wealth of bioactive compounds in red clover (Trifolium pratense ) seeds and their oil, ...

Fintel reports that on October 7, 2024, UBS initiated coverage of Clover Health Investments (NasdaqGS:CLOV) with a Neutral ...

Clover Health (CLOV) stock gains and Humana (HUM) stock falls as the Centers for Medicare & Medicaid Services ...

Clover Health Investments shares are trading higher by 4.6% Friday afternoon. The company announced that CMS raised its PPO Medicare Advantage plans' Star rating to 4 Stars for 2025.

Highlights,Clover Health’s PPO Medicare Advantage plans have received a Star rating increase to 4 Stars for 2025, impacting ...

Analyses of 2025 Medicare Advantage star ratings continue to pour in and not all of it bodes well for the conventional ...